Citius Oncology, Inc. CTOR
NASDAQ · United States · Health Technology
$1.01-0.01 (-0.50%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 2026-08-14 | -0.08 | -0.07 | -14.3% | $1.49M | -40.2% | -10.5%$0.83→$0.74 |
| Q2 2026 | 2026-05-15 | -0.27 | -0.01 | -2,600.0% | — | — | -15.8%$0.98→$0.83 |
| Q1 2026 | 2026-02-13 | -0.06 | -0.04 | -50.0% | — | — | 0.0%$1.18→$1.18 |
| Q4 2025 | 2025-12-23 | -0.06 | -0.06 | 0.0% | — | — | -8.4%$1.25→$1.14 |
| Q3 2025 | 2025-08-12 | -0.08 | -0.15 | +46.7% | — | — | — |
| Q2 2025 | 2025-05-14 | -0.11 | -0.09 | -22.2% | — | — | — |
| Q1 2025 | 2025-02-14 | -0.09 | -0.06 | -50.0% | — | — | — |
| Q4 2024 | 2024-12-27 | -0.10 | -0.08 | -25.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.